| Amy Lynne Ishak, APRN | |
|
99 Beauvoir Ave, Summit, NJ 07901-3533 | |
| (908) 522-5310 | |
| Not Available |
| Full Name | Amy Lynne Ishak |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 18 Years |
| Location | 99 Beauvoir Ave, Summit, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043473903 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 26NJ00162600 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yuma Regional Medical Center | Yuma, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| 303 Emergency Physicians Pllc | 2567692528 | 46 |
| Quality Urgent Care Professional Corporation | 5092053751 | 17 |
News Archive
The salivary glands of some tick species could become important research tools for studying how viruses are transmitted from ticks to mammals, and for developing preventive medical countermeasures.
Body weight in young adulthood and diet appeared to be associated with the risk for non-Hodgkin lymphoma, according to results presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011.
Men diagnosed with prostate cancer have a number of treatments to choose from, but it's a daunting task to figure out the right mix of therapies for an individual patient.
Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).
› Verified 4 days ago
| Entity Name | 303 Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518398585 PECOS PAC ID: 2567692528 Enrollment ID: O20140313001083 |
News Archive
The salivary glands of some tick species could become important research tools for studying how viruses are transmitted from ticks to mammals, and for developing preventive medical countermeasures.
Body weight in young adulthood and diet appeared to be associated with the risk for non-Hodgkin lymphoma, according to results presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011.
Men diagnosed with prostate cancer have a number of treatments to choose from, but it's a daunting task to figure out the right mix of therapies for an individual patient.
Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Lynne Ishak, APRN 3403 Balsam Way, Basking Ridge, NJ 07920-3157 Ph: () - | Amy Lynne Ishak, APRN 99 Beauvoir Ave, Summit, NJ 07901-3533 Ph: (908) 522-5310 |
News Archive
The salivary glands of some tick species could become important research tools for studying how viruses are transmitted from ticks to mammals, and for developing preventive medical countermeasures.
Body weight in young adulthood and diet appeared to be associated with the risk for non-Hodgkin lymphoma, according to results presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011.
Men diagnosed with prostate cancer have a number of treatments to choose from, but it's a daunting task to figure out the right mix of therapies for an individual patient.
Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).
› Verified 4 days ago
Cynthia E Cross, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 973-971-5595 | |
Elfie Wegner, RN P Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 33 Overlook Rd, Summit, NJ 07901 Phone: 973-971-7184 | |
Ms. Danielle Knight, APN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 11 Overlook Road, Mac Ii Building, Suite Ll 101, Summit, NJ 07901 Phone: 908-522-5900 Fax: 908-522-5544 | |
Darnell Hassan Stith Jr., APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 | |
Sarah Barnett, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Springfield Ave, Pulmonary And Allergy Associates, Summit, NJ 07901 Phone: 908-934-0555 Fax: 908-934-0558 | |
Jennifer Lillian O'neill, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 33 Overlook Rd Ste 201, Summit, NJ 07901 Phone: 908-522-5040 Fax: 908-522-5041 |